Hiroyuki Osanai

846 total citations
45 papers, 459 citations indexed

About

Hiroyuki Osanai is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroyuki Osanai has authored 45 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroyuki Osanai's work include Cardiac Arrhythmias and Treatments (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Hiroyuki Osanai is often cited by papers focused on Cardiac Arrhythmias and Treatments (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Hiroyuki Osanai collaborates with scholars based in Japan, United States and Switzerland. Hiroyuki Osanai's co-authors include Kenji Okumura, Toyoaki Murohara, Masayoshi Ajioka, Takayuki Ito, Yasushi Numaguchi, Mitsunori Harada, Kazuyoshi Sakai, Shinji Mokuno, Hiroshi Asano and Yukio Toki and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Hiroyuki Osanai

36 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Osanai Japan 12 199 117 111 71 66 45 459
Zaher Raslan United Kingdom 12 135 0.7× 81 0.7× 135 1.2× 42 0.6× 41 0.6× 13 442
Zhiyong Qi China 11 206 1.0× 159 1.4× 184 1.7× 38 0.5× 52 0.8× 27 584
Marzena Jurek United States 11 251 1.3× 129 1.1× 66 0.6× 60 0.8× 31 0.5× 20 554
Giovanna Baccante Italy 15 116 0.6× 95 0.8× 172 1.5× 50 0.7× 85 1.3× 19 546
A M Eiroa United States 6 175 0.9× 76 0.6× 112 1.0× 50 0.7× 98 1.5× 6 623
Angela Maria Stingone Italy 5 201 1.0× 154 1.3× 210 1.9× 81 1.1× 38 0.6× 6 463
Barsom Aktas Germany 9 392 2.0× 146 1.2× 193 1.7× 94 1.3× 86 1.3× 11 902
Eti Alessandra Femia Italy 14 237 1.2× 82 0.7× 92 0.8× 36 0.5× 29 0.4× 34 540
Hisakazu Suefuji Japan 16 390 2.0× 150 1.3× 137 1.2× 53 0.7× 27 0.4× 25 772
Foo Leong Li‐Saw‐Hee United Kingdom 11 401 2.0× 57 0.5× 100 0.9× 70 1.0× 39 0.6× 13 601

Countries citing papers authored by Hiroyuki Osanai

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Osanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Osanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Osanai more than expected).

Fields of papers citing papers by Hiroyuki Osanai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Osanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Osanai. The network helps show where Hiroyuki Osanai may publish in the future.

Co-authorship network of co-authors of Hiroyuki Osanai

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Osanai. A scholar is included among the top collaborators of Hiroyuki Osanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Osanai. Hiroyuki Osanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakamoto, Yusuke, et al.. (2025). Beyond the Pulmonary Veins: The Influence of Pulsed Field Ablation on the Superior Vena Cava. Journal of Arrhythmia. 41(6). e70249–e70249.
3.
Osanai, Hiroyuki, Yuki Tanaka, Takashi Watanabe, et al.. (2024). Distribution of anti‐factor Xa activity in patients with nonvalvular atrial fibrillation receiving 15 mg dose of edoxaban. Journal of Arrhythmia. 40(5). 1126–1130.
4.
Kambara, Takahiro, Rei Shibata, Hiroyuki Osanai, et al.. (2024). Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia. BMC Research Notes. 17(1). 60–60. 3 indexed citations
5.
Osanai, Hiroyuki, et al.. (2021). Isolated bilateral external iliac artery dissections with emotional stress. SHILAP Revista de lepidopterología. 9(3). 1312–1314. 2 indexed citations
6.
Sakamoto, Yusuke, et al.. (2021). A case of accessory pathway mapped with ultra‐high‐resolution mapping led to a coronary sinus diverticulum. SHILAP Revista de lepidopterología. 9(3). 1315–1320. 1 indexed citations
7.
Sakamoto, Yusuke, et al.. (2021). Contrast-enhanced computed tomography for optimizing the outcomes of pulmonary vein isolation with cryoablation -the role of isolation of PVs including carina-. Journal of Interventional Cardiac Electrophysiology. 64(2). 455–461. 1 indexed citations
8.
Osanai, Hiroyuki, et al.. (2020). Secondary Cardiac Lymphoma Presenting as Sick Sinus Syndrome and Atrial Fibrillation Which Required Leadless Pacemaker Implantation. Internal Medicine. 60(3). 431–434. 7 indexed citations
9.
Kambara, Takahiro, Rei Shibata, Yosuke Inoue, et al.. (2018). P272Additional use of SGLT2 inhibitors in the treatment of acute decompensated heart failure may prevent acute kidney injury. European Heart Journal. 39(suppl_1). 1 indexed citations
10.
Kuwayama, Tasuku, Hiroyuki Osanai, Masayoshi Ajioka, et al.. (2017). Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non‐valvular atrial fibrillation. Journal of Arrhythmia. 33(6). 619–623. 21 indexed citations
11.
Nishikawa, Kazuhiro, S. Yoshino, Satoshi Morita, et al.. (2017). Safety and efficacy of S-1 treatment in elderly patients with advanced or recurrent gastric cancer: A subgroup analysis from the phase III JFMC36-0701 trial. Annals of Oncology. 28. v231–v232.
12.
Nakano, Yoshihisa, Takahisa Kondo, Hiroyuki Osanai, et al.. (2014). Clinical usefulness of measuring prothrombin time and soluble fibrin levels in Japanese patients with atrial fibrillation receiving rivaroxaban. Journal of Cardiology. 65(3). 185–190. 17 indexed citations
13.
Nara, Kazuhiro, et al.. (2011). Influence of Culture Medium on the Composition of Water-soluble Polysaccharides in Ganoderma lucidum Fruit Body. Nippon Shokuhin Kagaku Kogaku Kaishi. 58(5). 216–221. 1 indexed citations
14.
Numaguchi, Yasushi, Takahito Sone, Kenji Okumura, et al.. (2006). The Impact of the Capability of Circulating Progenitor Cell to Differentiate on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction. Circulation. 114(1_supplement). I114–9. 88 indexed citations
15.
Asano, Hiroshi, Kazuyoshi Sakai, Masayoshi Ajioka, et al.. (2004). PJ-240 The "Rentrop 2" Collateral Flow Will Salvage the Myocardium in Acute Myocardial Infarction?(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 8 (IHD) : PJ40)(Poster Session (Japanese)). Japanese Circulation Journal-english Edition. 68. 538. 1 indexed citations
16.
Okumura, Kenji, Yoshio Iwama, Shinji Mokuno, et al.. (1999). Oxygen-Derived Free Radical-Induced Vasoconstriction by Thromboxane A2 in Aorta of the Spontaneously Hypertensive Rat. Journal of Cardiovascular Pharmacology. 33(4). 605–610. 45 indexed citations
18.
Osanai, Hiroyuki, et al.. (1998). Gastric outlet syndrome caused by a gallstone: Report of a case. Surgery Today. 28(4). 412–415. 9 indexed citations
19.
Osanai, Hiroyuki, et al.. (1987). Clinical studies on extent of resection and complications in the aged patients with gastric cancer.. The Japanese Journal of Gastroenterological Surgery. 20(10). 2295–2298. 2 indexed citations
20.
Osanai, Hiroyuki, et al.. (1978). [Effect of dexamethasone in endotoxin shock--difference in anti-toxic potency among ester types of dexamethasone (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(4). 355–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026